• Newsletters
  • Gift Membership
Logo Logo
Take Scroll With You Download the app to read our award-winning journalism on the go and stay up-to-date with our notifications.
Get the app Get the app
ANDROID iOS
  • Home
  • Common Ground
  • The India Fix
  • Eco India
  • The Latest
  • The Reel
  • Magazine
  • Video
  • Trending
    • A hidden debt crisis is silently wrecking the dreams of India’s middle class
    • India hyphen Pakistan: US rhetoric revives New Delhi’s nightmare
    • ‘By tearing off the skin with your teeth’: The right way to eat mangoes according to Victorian women
    • The Congolese philosopher who liberated ‘Africa’ from the chains of Western thought
    • What excess death data shows: Bihar, Gujarat undercounted Covid-19 toll by 30 times
    • For children: Child widow Aru’s life changes when she’s offered a job at the landlord’s house
    • Four questions Indians must ask about Operation Sindoor
    • Harsh Mander: Pahalgam and after – the singular burden of apology
    • Drones after dusk: Is this the ‘new normal’ on India’s western front?
    • A new book examines the historical context of the Airavatesvara Temple, built during the Chola rule
    • Are we ready for our final reckoning with Tom Cruise’s ‘Mission: Impossible’ movies?
    • Why US court’s fine on Israeli firm operating Pegasus is an indictment of the Indian Supreme Court
  • Sections
    • Politics
    • Culture
    • India
    • World
    • Film and TV
    • Music
    • Books and Ideas
    • Business and Economy
    • Science and Technology
    • In Pictures
    • Announcements
    • Bookshop
    • The Field
    • Pulse
    • Elections 2024

spinal muscular atrophy

  • HC allows Natco Pharma to make Swiss firm Roche’s spinal muscular atrophy drug in public interest

    HC allows Natco Pharma to make Swiss firm Roche’s spinal muscular atrophy drug in public interest

    Scroll Staff
    · Mar 26, 2025 · 01:25 pm